Boenning & Scattergood Upgrades Xylem To Outperform
Analysts at Boenning & Scattergood upgraded Xylem Inc. (NYSE: XYL) from Neutral to Outperform.
The price target for Xylem is set to $40.
Xylem shares have dropped 7.28% over the past 52 weeks, while the S&P 500 index has surged 9.36% in the same period.
Xylem shares closed at $35.02 in pre-market trading.
Latest Ratings for XYL
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Credit Suisse | Maintains | Underperform | |
| Jan 2022 | Raymond James | Downgrades | Market Perform | Underperform |
| Dec 2021 | Mizuho | Initiates Coverage On | Neutral |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Boenning & ScattergoodUpgrades Analyst Ratings
